title: No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: potential explanations.
authors: 1 Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center , Sacramento, California.
authors: Ishwarlal
authors: I
authors: Jialal
authors: Sandeep
authors: S
authors: Dhindsa
mesh_terms: D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control*; D004151:Dipeptides / Q000009:adverse effects / Q000627:therapeutic use*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic
chemical_list: D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; C502994:saxagliptin; D000218:Adamantane